A method of treating a human patient with a hypercoagulable state or protein C deficiency, which comprises administering activated Protein C and protein C Zymogen.

 
Web www.patentalert.com

< Rare limiting barriers for implantable medical devices

< Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof

> Method for producing a fermented hydrolyzed medium containing microorganisms

> Methanocarba cycloakyl nucleoside analogues
~ 00281